In addition, from Eli Lilly, Alan Lamont, Executive Director Global External Research & Development, will join the debate on ‘Investing in innovation to make a return — organising the value chain to deliver a return on shareholder capital?’, and from Sanofi-Aventis, Denis Croisat, Director Lead Generation — CMC, Biologics Sourcing & External Business Opportunities, will offer his expertise and exchange opinions with fellow panellists on ‘East vs West: Future Trends in Partnering Discovery and CMC Activities.’
Joining one of the opening sessions on day two that will explore ‘The Tougher Side of Iintegration — What Part Should Regulators and Patients Play?’ will be Drew Hope, Head of Advanced Therapy Quality, ATMP GMP Unit, NIHR Biomedical Research Centre, Guy’s and St Thomas’s NHS Foundation Trust & King’s College London.
Also, Zach System S.p.A and GXPi are the latest companies to endorse Pharma Integrates, joining Nextpharma, Recipharm and 3M as Silver sponsors this year. Additional Platinum and Gold sponsors of the widely acclaimed, annual pharmaceutical conference include Catalent Pharma Solutions, Patheon Inc., Baxter BioPharma Solutions, SAFC Global, Piramal Pharma Healthcare and CordenPharma.
Pharma Integrates 2013 will take place on 26–27 November at the Riverbank Park Plaza, London, UK. Further information is available on the LSI website.